OPT
Click for more information
0.00% 40.5¢ opthea limited

Ann: Opthea Completes Enrollment in First Trial of Sozinibercept, page-8

  1. simons77
    648 Posts.
    lightbulb Created with Sketch. 161
    clock Created with Sketch.
    15/02/24
    10:47
    Post #: 72418626
    that mean we wont see fda approval until 2027.... more diluation
    OPT Price at posting: 59.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
40.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $498.5M
Open High Low Value Volume
40.5¢ 42.5¢ 38.8¢ $1.099M 2.714M

Buyers (Bids)

No. Vol. Price($)
4 266232 40.5¢
 

Sellers (Offers)

Price($) Vol. No.
41.5¢ 217540 3
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.